IL1B and type 1 diabetes mellitus: In contrast to the significant reduction in oxidative stress observed in T1D patients with resveratrol treatment, there was no significant decrease/increase in the levels of proinflammatory markers, such as CRP, TNF-α, and IL-1β in this study.